First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - DRUGSCOPE

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: DRUGSCOPE, 264 Banbury Road, Oxford, OX2 7DY. The legal status is a Private Limited By Guarantee Without Share Capital and the current status at the registry of companies is Dissolved. The last filed accounts are dated 31 March 2014. The company was incorporated on 24 January 1968.

The accounts next due date is 31 December 2015. There are 5 mortgages, 1 satisfied, none part satisfied and 4 unsatisfied.

The above was based on public record information as at 2 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 00926236
Date Incorporated: 24 January 1968
Date Latest Accounts: 31 March 2014
BUSINESS INFORMATION
Legal Form: Private Limited By Guarantee Without Share Capital
Previous Names: INSTITUTE FOR THE STUDY OF DRUG DEPENDENCE LIMITED(THE)
Registered Number: 00926236
Annual Return: 29 October 2014
Registered Office: 264 Banbury Road, Oxford, OX2 7DY
SIC Code and Operations: 94990
SECURED CREDITORS
Number of Mortgages 5
Satisfied Mortgages 1
Part Satisfied Mortgages 0
Unsatisfied Mortgages 4
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

DRUGSCOPE

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 12 January 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09488433 DRUGSDIRECT GLOBAL LTD Liquidation
03744459 DRUGSDIRECT LIMITED Liquidation
07346924 DRUGSLINE (UK) LIMITED Dissolved
14039095 DRUGSLINE EDUCATION LTD Active
08331494 DRUGSLINE LIMITED Dissolved

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd